BGB-11417
BGB-11417-102
Phase 1 small_molecule active
Quick answer
BGB-11417 for Mature B-cell Malignancies is a Phase 1 program (small_molecule) at BeOne Medicines with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BeOne Medicines
- Indication
- Mature B-cell Malignancies
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active